JPH0725749B2 - Ｎ‐ピリジニル‐９ｈ‐カルバゾール‐９‐アミン類 - Google Patents

Ｎ‐ピリジニル‐９ｈ‐カルバゾール‐９‐アミン類

Info

Publication number
JPH0725749B2
JPH0725749B2 JP1335256A JP33525689A JPH0725749B2 JP H0725749 B2 JPH0725749 B2 JP H0725749B2 JP 1335256 A JP1335256 A JP 1335256A JP 33525689 A JP33525689 A JP 33525689A JP H0725749 B2 JPH0725749 B2 JP H0725749B2
Authority
JP
Japan
Prior art keywords
lower alkyl
hydrogen
halogen
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP1335256A
Other languages
English (en)
Japanese (ja)
Other versions
JPH02247173A (ja
Inventor
リチヤード・チヤールズ・エフランド
ジヨゼフ・トマス・クライン
ラリー・デイビス
ゴードン・エドワード・オルセン
Original Assignee
ヘキストールセル・フアーマシユウテイカルズ・インコーポレイテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヘキストールセル・フアーマシユウテイカルズ・インコーポレイテツド filed Critical ヘキストールセル・フアーマシユウテイカルズ・インコーポレイテツド
Publication of JPH02247173A publication Critical patent/JPH02247173A/ja
Publication of JPH0725749B2 publication Critical patent/JPH0725749B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP1335256A 1988-12-27 1989-12-26 Ｎ‐ピリジニル‐９ｈ‐カルバゾール‐９‐アミン類 Expired - Fee Related JPH0725749B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US289,887 1988-12-27
US07/289,887 US4868190A (en) 1988-12-27 1988-12-27 N-pyridinyl-9H-carbazol-9-amines

Publications (2)

Publication Number Publication Date
JPH02247173A JPH02247173A (ja) 1990-10-02
JPH0725749B2 true JPH0725749B2 (ja) 1995-03-22

Family

ID=23113557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1335256A Expired - Fee Related JPH0725749B2 (ja) 1988-12-27 1989-12-26 Ｎ‐ピリジニル‐９ｈ‐カルバゾール‐９‐アミン類

Country Status (19)

Country Link
US (1) US4868190A (en:Method)
EP (1) EP0376155B1 (en:Method)
JP (1) JPH0725749B2 (en:Method)
KR (1) KR900009596A (en:Method)
AT (1) ATE79118T1 (en:Method)
AU (1) AU623205B2 (en:Method)
CA (1) CA2006529C (en:Method)
DE (1) DE68902386T2 (en:Method)
DK (1) DK662189A (en:Method)
ES (1) ES2044043T3 (en:Method)
FI (1) FI896243A7 (en:Method)
GR (1) GR3006140T3 (en:Method)
IE (1) IE894175L (en:Method)
IL (1) IL92867A0 (en:Method)
NO (1) NO895222L (en:Method)
NZ (1) NZ231943A (en:Method)
PH (1) PH27122A (en:Method)
PT (1) PT92696A (en:Method)
ZA (1) ZA899904B (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
ATE118002T1 (de) * 1989-08-02 1995-02-15 Hoechst Roussel Pharma 2,3-dihydro-1-(pyridinylamino)-indole, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
KR100445629B1 (ko) * 1995-07-27 2004-10-14 아벤티스 파마슈티칼스 인크. 비치환및치환된n-(피롤-1-일)피리딘아민의항경련제로서의용도
US5776955A (en) * 1995-07-27 1998-07-07 Hoechst Marion Roussel, Inc. Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
EP1305082B1 (en) * 2000-07-21 2004-05-26 Ortho-McNeil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475982A (de) * 1966-11-16 1969-07-31 Wander Ag Dr A Verfahren zur Herstellung von Carbazolderivaten
EP0073849A1 (en) * 1981-09-03 1983-03-16 Schering Corporation Novel phenyl-1,2,3,4-tetrahydrocarbazoles, their preparation and pharmaceutical compositions containing them
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
ATE115143T1 (de) * 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
ATE118002T1 (de) * 1989-08-02 1995-02-15 Hoechst Roussel Pharma 2,3-dihydro-1-(pyridinylamino)-indole, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Also Published As

Publication number Publication date
JPH02247173A (ja) 1990-10-02
NO895222D0 (no) 1989-12-22
ZA899904B (en) 1991-02-27
FI896243A7 (fi) 1990-06-28
AU4720389A (en) 1990-07-05
DK662189D0 (da) 1989-12-22
PH27122A (en) 1993-03-16
DE68902386T2 (de) 1993-02-11
KR900009596A (ko) 1990-07-05
NZ231943A (en) 1992-06-25
DK662189A (da) 1990-06-28
CA2006529A1 (en) 1990-06-27
IE894175L (en) 1990-06-27
GR3006140T3 (en:Method) 1993-06-21
NO895222L (no) 1990-06-28
FI896243A0 (fi) 1989-12-22
ES2044043T3 (es) 1994-01-01
ATE79118T1 (de) 1992-08-15
AU623205B2 (en) 1992-05-07
EP0376155B1 (en) 1992-08-05
US4868190A (en) 1989-09-19
CA2006529C (en) 1999-08-10
PT92696A (pt) 1990-06-29
IL92867A0 (en) 1990-09-17
EP0376155A1 (en) 1990-07-04
DE68902386D1 (de) 1992-09-10

Similar Documents

Publication Publication Date Title
FI86421C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 9-amino-1,2,3,4-tetrahydroakridin-1-oler.
DE3781195T2 (de) Substituierte benzamidderivate, verfahren zu deren herstellung und diese enthaltende medikamente.
ES2311563T3 (es) Derivados de indolina y su utilizacion como ligandos del receptor de 5-ht2.
DE60218037T2 (de) Neue indolderivate mit affinität zum 5-ht6-rezeptor
DE69518373T2 (de) Neue Zusammensetzungen, die Sertralin und einem 5-HT1D-Rezeptoragonisten oder Antagonisten enthalten
EP0858996B1 (en) Nerve cell protective agents
DE69930308T2 (de) Selektive 5-ht 6-rezeptor-liganden
CZ288944B6 (cs) Derivát 5H-thiazolo[3,2-a]pyrimidinu, způsob jeho přípravy, meziprodukt pro jeho přípravu a farmaceutický prostředek, který ho obsahuje
EP1072263A1 (en) Amide derivatives and nociceptin antagonists
CS223977B2 (en) Method of preparation of the chinazoline derivatives
JP2019518754A (ja) フッ素化２−アミノ−４−（置換アミノ）フェニルカルバメート誘導体
TW201211007A (en) Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
DE69016530T2 (de) 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
JP2013502432A (ja) Ｐｄｅ４の二環式ヘテロアリール阻害剤
FI97544C (fi) Menetelmä lääkeaineina käyttökelpoisten 1-(pyrido/3,4-b/-1,4-oksatsin-4-yyli)-1H-indolien valmistamiseksi
JPH0725749B2 (ja) Ｎ‐ピリジニル‐９ｈ‐カルバゾール‐９‐アミン類
US6028073A (en) N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics
DE69329084T2 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
JP2021506810A (ja) フッ素化４−（置換アミノ）フェニルカルバメート誘導体
JP7634083B2 (ja) 新規なピラゾール誘導体
EA008907B1 (ru) Производные индола
HUP0100926A2 (hu) Benzilpiperazinil- és benzilpiperidiniletanon-származékok, előállításuk és alkalmazásuk dopamin D4 receptor antagonistaként
DE69420345T2 (de) Benzothiazolsulfonamid-derivate, verfahren zu deren herstellung und anwendungen
KR100191386B1 (ko) 3-(1,2-벤즈이속사졸-3-일)-4-피리딘아민 및 유도체,이를 함유하는 약제학적 조성물 및 이의 제조방법
Kashaw et al. Design, synthesis and potential CNS activity of some novel 1-(4-substituted-phenyl)-3-(4-oxo-2-propyl-4H-quinazolin-3-yl)-urea

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees